The IgG1 isotype of anti-MDA5 antibody may dominate severity of interstitial lung disease in dermatomyositis

被引：0
|
作者：
Chen, M. [1 ]
Zheng, J. [1 ]
Pan, M. [1 ]
Cao, H. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Dept Dermatol, Shanghai, Peoples R China
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2020年 / 140卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
903
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wanlong Wu
    Li Guo
    Yakai Fu
    Kaiwen Wang
    Danting Zhang
    Wenwen Xu
    Zhiwei Chen
    Shuang Ye
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 293 - 304
  • [2] Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
    Wu, Wanlong
    Guo, Li
    Fu, Yakai
    Wang, Kaiwen
    Zhang, Danting
    Xu, Wenwen
    Chen, Zhiwei
    Ye, Shuang
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (02) : 293 - 304
  • [3] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE DUE TO ANTI-MDA5 ANTIBODY WITHOUT DERMATOMYOSITIS
    Qadri, Anum N.
    Jimenez, Javier Blanco
    CHEST, 2024, 166 (04) : 3367A - 3368A
  • [4] Progressive Interstitial Lung Disease Associated With Anti-MDA5 Positive Dermatomyositis
    Vahabzadeh, A.
    Ventimiglia, W. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [5] Rapidly Progressive Interstitial Lung Disease Associated with Anti-MDA5 Dermatomyositis
    Thomas, M.
    Deshpande, P.
    Tran, L.
    Sampath, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANTI-MDA5 POSITIVE DERMATOMYOSITIS
    Vahabzadeh, Arshia
    Ventimiglia, William A.
    CHEST, 2023, 164 (04) : 3217A - 3217A
  • [7] Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis
    Lin, Rachel R.
    Warp, Peyton V.
    Maderal, Andrea D.
    Elman, Scott A.
    JAMA DERMATOLOGY, 2024, 160 (05) : 575 - 577
  • [8] Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Gono, Takahisa
    Sato, Shinji
    Kawaguchi, Yasushi
    Kuwana, Masataka
    Hanaoka, Masanori
    Katsumata, Yasuhiro
    Takagi, Kae
    Baba, Sayumi
    Okamoto, Yuko
    Ota, Yuko
    Yamanaka, Hisashi
    RHEUMATOLOGY, 2012, 51 (09) : 1563 - 1570
  • [9] Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
    Jiang, Lili
    Wang, Youlian
    Peng, Qinglin
    Shu, Xiaoming
    Wang, Guochun
    Wu, Xiaomu
    CLINICAL RHEUMATOLOGY, 2019, 38 (06) : 1655 - 1663
  • [10] Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody
    Lili Jiang
    Youlian Wang
    Qinglin Peng
    Xiaoming Shu
    Guochun Wang
    Xiaomu Wu
    Clinical Rheumatology, 2019, 38 : 1655 - 1663
12345